Contact
searchSearch
HMP Global
Videos

What's New With the European Chapter of the CLI Global Society

Jos C. van den Berg, MD, PhD
Thomas Zeller, MD, PhD
12/02/2024

In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical limb ischemia.

For more information, visit www.cliglobalsociety.org

News

News
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k)...
09/08/2025
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia
AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use